Anus

Long-Term Follow-up Data on Sustained Immunogenicity and Safety for GARDASIL®9 Published in Pediatrics

Retrieved on: 
Tuesday, September 5, 2023

The oropharyngeal and head and neck cancer indication is approved under accelerated approval based on effectiveness in preventing HPV-related anogenital disease.

Key Points: 
  • The oropharyngeal and head and neck cancer indication is approved under accelerated approval based on effectiveness in preventing HPV-related anogenital disease.
  • Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.
  • As part of the primary objective of immunogenicity, data showed sustained HPV-antibody responses at 10 years after the third dose in boys and girls.
  • With the exception of cervical cancer, there is no routinely recommended screening for the detection of HPV-related cancers.

TerraZero Technologies Inc. Offers Corporate Update & Business Development Amid Rapidly Growing Metaverse Adoption

Retrieved on: 
Thursday, April 21, 2022

The Company focuses on three main business areas: its development studio, its software platform division, and its data analytics unit.

Key Points: 
  • The Company focuses on three main business areas: its development studio, its software platform division, and its data analytics unit.
  • TerraZero is ideally positioned in a rapidly growing technology sector with a potential of 2.0 bil.
  • In addition, TerraZero owns significant amounts of virtual land assets in multiple metaverse worlds, and is one of the largest landowners in Decentraland ( www.decentraland.org ).
  • TerraZero is a vertically integrated Metaverse development group and leading Web 3.0 technology company specializing in the Metaverse space.

Healing Bottoms Founder, Mrs. Ford, Introduces a New Turmeric Supplement for IBD & IBS

Retrieved on: 
Tuesday, February 2, 2021

Unlike typical prescription drugs used to treat the proceeding, the all natural capsules do not carry side affects.

Key Points: 
  • Unlike typical prescription drugs used to treat the proceeding, the all natural capsules do not carry side affects.
  • Over 60% of consumers pair the supplement with "Healing Bottoms Turmeric Suppositories."
  • The Founder credits her small research team, and loyal consumer as the driving force to creating new innovative alternative medicines.
  • HB Product line consist of Max Turmeric Supplements, Turmeric Suppositories, Thrombosed Hemorrhoid Removal, Wound Healing Wipes, Detox Tea, M- Serum Cell Repair, and Bartholin Gland Cyst Drainage.

Doppler Technology Helps Heal Common, Painful Health Issue

Retrieved on: 
Friday, June 5, 2020

The THD Doppler Hemorrhoid System uses ultrasound technology to identify and ligate the arteries that cause painful hemorrhoidal symptoms.

Key Points: 
  • The THD Doppler Hemorrhoid System uses ultrasound technology to identify and ligate the arteries that cause painful hemorrhoidal symptoms.
  • As many as 75 percent of people over the age of 45 are affected with the issue.
  • Colorectal surgeon Samuel R. Luka, M.D., uses the innovative technology at Durango Outpatient Surgery Center to help relieve the disabling symptoms associated with hemorrhoids.
  • "THD is done as an outpatient procedure and allows most patients to get back to work and normal activities quickly," Dr. Luka said.

Global Hemorrhoid Treatment Devices Market Industry Analysis, Size, Share, Growth & Trends: Forecast 2018-2026 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 18, 2019

The "Hemorrhoid Treatment Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hemorrhoid Treatment Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026" report has been added to ResearchAndMarkets.com's offering.
  • The global hemorrhoid treatment devices market is growing at a rapid pace due to increase in advancements in treating hemorrhoids.
  • Therefore, rise in need and demand for advanced products that increase therapeutic outcome propels the global hemorrhoid treatment devices market.
  • Based on end-user, the global hemorrhoid treatment devices market has been divided into hospital & clinics, ambulatory surgical centers, and others.

Peritech Pharma Granted Patents for China and Russia

Retrieved on: 
Tuesday, May 14, 2019

HERZLIYA, Israel, May 14, 2019 /PRNewswire/ -- Peritech Pharma , a specialty anal-rectal pharmaceutical company, today announced it has been granted patents covering China and Russia for its drug delivery platform used for two of its over-the-counter products, PP-110 for hemorrhoids and PP-120 for anal itching.

Key Points: 
  • HERZLIYA, Israel, May 14, 2019 /PRNewswire/ -- Peritech Pharma , a specialty anal-rectal pharmaceutical company, today announced it has been granted patents covering China and Russia for its drug delivery platform used for two of its over-the-counter products, PP-110 for hemorrhoids and PP-120 for anal itching.
  • These new patents, which also apply to topical skin treatment technology under a license to Topitech Pharma, protect the mechanism that provides patients longer relief from symptoms with fewer applications needed per day.
  • "We are very excited to obtain patents for Russia, and especially China which represents a significant and fast-growing market," said Peritech founder and CEO Dr. Eran Eilat.
  • Founded in 2012, Peritech Pharma is a privately held specialty anal-rectal pharmaceutical company, targeting numerous indications with large markets and clear unmet medical needs.

Insights into the Global Hemorrhoid Treatment Devices Market, 2019 - A $963.1 Million Opportunity by 2026

Retrieved on: 
Thursday, April 25, 2019

The global hemorrhoid treatment devices market was valued at US$ 616.2 Mn in 2017 and is expected to reach US$ 963.1 Mn by 2026, expanding at a CAGR of 4.9% from 2018 to 2026.

Key Points: 
  • The global hemorrhoid treatment devices market was valued at US$ 616.2 Mn in 2017 and is expected to reach US$ 963.1 Mn by 2026, expanding at a CAGR of 4.9% from 2018 to 2026.
  • On the other hand, hospitals observe the largest patient footfall for hemorrhoid treatment and therefore is the biggest usage area for hemorrhoid treatment devices.
  • In terms of renal demarcation, North America dominates the global hemorrhoid treatment devices market.
  • Considering the competitive landscape, the global hemorrhoid treatment devices market is highly fragmented with several companies together capturing over 50% share of the global market.

Global Hemorrhoid Treatment Devices Market Size & Share; 2018 to 2026 (2019 Study) - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 18, 2019

The "Global Hemorrhoid Treatment Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 to 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Hemorrhoid Treatment Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 to 2026" report has been added to ResearchAndMarkets.com's offering.
  • The global hemorrhoid treatment devices market was valued at US$ 616.2 Mn in 2017 and is expected to reach US$ 963.1 Mn by 2026, expanding at a CAGR of 4.9% from 2018 to 2026.
  • On the other hand, hospitals observe the largest patient footfall for hemorrhoid treatment and therefore is the biggest usage area for hemorrhoid treatment devices.
  • Considering the competitive landscape, the global hemorrhoid treatment devices market is highly fragmented with several companies together capturing over 50% share of the global market.